Characterising the HIV self-testing market in Kenya: Awareness and usage, barriers and motivators to uptake, and propensity to pay.

Autor:	West RL; Ipsos, London, United Kingdom.; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, United States of America., Freeman L; Ipsos, London, United Kingdom., Pahe C; Population Services Kenya, Nairobi, Kenya., Momanyi H; Population Services Kenya, Nairobi, Kenya., Kidiga C; Population Services International, Nairobi, Kenya., Malaba S; Population Services International, Nairobi, Kenya., Ciecielag J; Ipsos, Warsaw, Poland., Ridge MC; Ipsos, London, United Kingdom., Goldwin E; Ipsos, London, United Kingdom., Awsumb H; Population Services International, Washington, D.C., United States of America., Sharma S; Ipsos, London, United Kingdom.
Jazyk:	angličtina
Zdroj:	PLOS global public health [PLOS Glob Public Health] 2023 Apr 05; Vol. 3 (4), pp. e0001776. Date of Electronic Publication: 2023 Apr 05 (Print Publication: 2023).
DOI:	10.1371/journal.pgph.0001776
Abstrakt:	HIVST has a key role in ensuring countries meet their 95-95-95 goals. For HIVST to be sustainable, we should explore sharing costs with users as well as the overall experience. This research explores why a consumer would use HIVST and willingness to pay for HIVST through surveying 1,021 participants 18-35 living in Nairobi or Kisumu who were not diagnosed as HIV positive and who are not currently taking PrEP for HIV. A majority (89.8%) would pay 100 KSH and 64.7% would pay 300 KSH, at higher prices likelihood of paying dropped sharply. Price reduction or subsidization coupled with interventions to address the identified barriers may increase HIVST uptake. We identified 5 distinct groups based on willingness to pay and drivers/ barriers to HIVST uptake. These were created using dimension reduction, hierarchical clustering, and k-means analysis to group respondents. 79% of participants had ever heard of HIVST, and 24% had ever used HIVST. The 5 groups included active users, unlikely users, and three segments interested in HIVST with different barriers: need for HCP support, need for increased privacy/confidentiality, and fear of positive result/disclosure. Competing Interests: The authors have declared that no competing interests exist. (Copyright: © 2023 West et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu